Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Jury Awards $450m In Class-Action Charging Fraud In Gown Infection-Protection Claims

Executive Summary

Halyard Health plans to appeal the verdict, which stems from allegations the company and its former parent, Kimberly-Clark, fraudulently promoted surgical gowns as offering more protection than they really did.

You may also be interested in...



US DOJ Settles With St. Jude, Alere, Avanos For Total Of $88M

The settlements resolve False Claims Act allegations against St. Jude and Alere, as well as misbranding allegations against Avanos Medical.

Kimberly-Clark Facing Multiple Suits On Gown Issues

A California court is allowing a class-action case filed by health-care professionals against the company to go forward, while competitor Medline files suit alleging false advertising. Kimberly-Clark allegedly promoted its MicroCool and Ultra surgical gowns as meeting high safety standards, even though they failed lab testing.

News We’re Watching: Lung Preservation System Goes National, De Novo For MMI, Brazil’s ANVISA To Recognize Overseas Approvals

This week, Paragonix announced that its BAROguard lung preservation system is now available throughout the US; Brazil planned to leverage some foreign device approvals; Medical Microinstruments’ Symani Surgical System won de novo clearance; and the FDA updated its safety warnings for Essure and certain plastic syringes.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT104716

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel